The embryonic Brachyury transcription factor is a novel biomarker of GIST aggressiveness and poor survival (Q41725776)

8 October 2017

title

The embryonic Brachyury transcription factor is a novel biomarker of GIST aggressiveness and poor survival (English)

1 reference

8 October 2017

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25995035%20AND%20SRC:MED&resulttype=core&format=json

Cristovam Scapulatempo-Neto

12 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25995035%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25995035%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25995035%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25995035%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

author name string

Nathalia C Campanella

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25995035%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Lucas F Abrahão-Machado

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25995035%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Antonio T de Oliveira

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25995035%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Maria J Brito

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25995035%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

publication date

21 May 2015

1 reference

8 October 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25995035%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25995035%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25995035%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

page(s)

651-659

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25995035%20AND%20SRC:MED&resulttype=core&format=json

Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: a review

12 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10120-015-0505-0

PDGFRA activating mutations in gastrointestinal stromal tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-015-0505-0

Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-015-0505-0

Low frequency of MAP kinase pathway alterations in KIT and PDGFRA wild-type GISTs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-015-0505-0

Gastrointestinal stromal tumours: from KIT to succinate dehydrogenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-015-0505-0

Biomarkers and novel therapeutic targets in gastrointestinal stromal tumors (GISTs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-015-0505-0

Gastrointestinal stromal tumour.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-015-0505-0

Acquired resistance to imatinib in gastrointestinal stromal tumor occurs through secondary gene mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-015-0505-0

Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-015-0505-0

T-box genes in early embryogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-015-0505-0

Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-015-0505-0

IL-8 signaling plays a critical role in the epithelial-mesenchymal transition of human carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-015-0505-0

The T-box transcription factor Brachyury promotes epithelial-mesenchymal transition in human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-015-0505-0

Brachyury, a driver of the epithelial-mesenchymal transition, is overexpressed in human lung tumors: an opportunity for novel interventions against lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-015-0505-0

T-box transcription factor brachyury is associated with prostate cancer progression and aggressiveness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-015-0505-0

The embryonic transcription factor Brachyury blocks cell cycle progression and mediates tumor resistance to conventional antitumor therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-015-0505-0

Activin A and Wnt-dependent specification of human definitive endoderm cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-015-0505-0

Chordoma of the mobile spine and sacrum: a retrospective analysis of a series of patients surgically treated at two referral centers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-015-0505-0

Gene expression signature-based prognostic risk score in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-015-0505-0

Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-015-0505-0

The landscape of somatic copy-number alteration across human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-015-0505-0

The gene expression profile of extraskeletal myxoid chondrosarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-015-0505-0

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-015-0505-0

Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-015-0505-0

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-015-0505-0

Correlation of kinase genotype and clinical outcome in the North American Intergroup Phase III Trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-015-0505-0

The human T-box mesodermal transcription factor Brachyury is a candidate target for T-cell-mediated cancer immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-015-0505-0

The T-box transcription factor Brachyury regulates epithelial-mesenchymal transition in association with cancer stem-like cells in adenoid cystic carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-015-0505-0

An autocrine loop between TGF-β1 and the transcription factor brachyury controls the transition of human carcinoma cells into a mesenchymal phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-015-0505-0

BRACHYURY confers cancer stem cell characteristics on colorectal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-015-0505-0

Immunological targeting of tumor cells undergoing an epithelial-mesenchymal transition via a recombinant brachyury-yeast vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-015-0505-0

Resection of residual disease in patients with metastatic gastrointestinal stromal tumors responding to treatment with imatinib.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-015-0505-0

DOG1 regulates growth and IGFBP5 in gastrointestinal stromal tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-015-0505-0

An in vivo tumor model exploiting metabolic response as a biomarker for targeted drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-015-0505-0

CT and PET: early prognostic indicators of response to imatinib mesylate in patients with gastrointestinal stromal tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-015-0505-0

Immune infiltrates are prognostic factors in localized gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-015-0505-0

ATF2 - at the crossroad of nuclear and cytosolic functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-015-0505-0

Cytoplasmic functions of the tumour suppressor p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-015-0505-0

Cancer vaccines targeting the epithelial-mesenchymal transition: tissue distribution of brachyury and other drivers of the mesenchymal-like phenotype of carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-015-0505-0

Co-expression of monocarboxylate transporter 1 (MCT1) and its chaperone (CD147) is associated with low survival in patients with gastrointestinal stromal tumors (GISTs)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-015-0505-0

T-box transcription factor Brachyury expression is correlated with epithelial-mesenchymal transition and lymph node metastasis in oral squamous cell carcinoma

21 January 2018

1 reference

12 December 2020

Diagnosis of gastrointestinal stromal tumors: A consensus approach

1 reference

12 December 2020

Loss of RKIP expression is associated with poor survival in GISTs

1 reference

12 December 2020

Low frequency of TERT promoter mutations in gastrointestinal stromal tumors (GISTs).

1 reference

12 December 2020

BMP4 promotes EMT and mesodermal commitment in human embryonic stem cells via SLUG and MSX2.

1 reference

12 December 2020

Origin and evolution of endoderm and mesoderm.

1 reference

12 December 2020

Expression of Brachyury gene is a significant prognostic factor for primary lung carcinoma.

1 reference

12 December 2020

Gastrointestinal stromal tumours: origin and molecular oncology.

1 reference

12 December 2020

Brachyury expression predicts poor prognosis at early stages of colorectal cancer

1 reference

12 December 2020

Lymphangiogenic VEGF-C and VEGFR-3 expression in genetically characterised gastrointestinal stromal tumours

1 reference

12 December 2020